

1,402,080 filings since 2004 · latest accepted Nov 4, 2026, 8:46 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Oct 27, 2026 accepted 4:44 PM ET | CRDFCardiff Oncology, Inc. | 5.02Officer / director change5.03Bylaws / fiscal year7.01Reg FD disclosure | DocumentSEC ↗ |
Oct 22, 2026 accepted 4:30 PM ET |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
5.07Shareholder vote |
| DocumentSEC ↗ |
Sep 14, 2026 accepted 9:28 AM ET | CRDFCardiff Oncology, Inc. | 1.01Material agreement7.01Reg FD disclosure | DocumentSEC ↗ |
Aug 11, 2026 accepted 4:11 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jul 16, 2026 accepted 8:38 AM ET | CRDFCardiff Oncology, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Jun 11, 2026 accepted 4:15 PM ET | CRDFCardiff Oncology, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
Jun 3, 2026 accepted 8:30 AM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
May 29, 2026 accepted 5:11 PM ET | CRDFCardiff Oncology, Inc. | 1.01Material agreement | DocumentSEC ↗ |
May 19, 2026 accepted 5:01 PM ET | CRDFCardiff Oncology, Inc. | 8.01Other events | DocumentSEC ↗ |
May 14, 2026 accepted 4:15 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Apr 9, 2026 accepted 4:10 PM ET | CRDFCardiff Oncology, Inc. | 5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Apr 2, 2026 accepted 4:15 PM ET | CRDFCardiff Oncology, Inc. | 1.01Material agreement5.02Officer / director change | DocumentSEC ↗ |
Feb 25, 2026 accepted 8:30 AM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Feb 24, 2026 accepted 5:09 PM ET | CRDFCardiff Oncology, Inc. | 2.01Acquisition / disposition | DocumentSEC ↗ |
Jan 27, 2026 accepted 4:01 PM ET | CRDFCardiff Oncology, Inc. | 5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Nov 6, 2025 accepted 4:08 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jul 29, 2025 accepted 4:10 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Jun 26, 2025 accepted 4:30 PM ET | CRDFCardiff Oncology, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
Jun 17, 2025 accepted 4:15 PM ET | CRDFCardiff Oncology, Inc. | 5.02Officer / director change8.01Other events | DocumentSEC ↗ |
May 8, 2025 accepted 4:10 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Feb 27, 2025 accepted 4:15 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jan 6, 2025 accepted 4:10 PM ET | CRDFCardiff Oncology, Inc. | 5.03Bylaws / fiscal year | DocumentSEC ↗ |
Dec 10, 2024 accepted 4:10 PM ET | CRDFCardiff Oncology, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Dec 10, 2024 accepted 6:02 AM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Nov 7, 2024 accepted 4:07 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Aug 8, 2024 accepted 4:06 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jun 20, 2024 accepted 4:03 PM ET | CRDFCardiff Oncology, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
Jun 3, 2024 accepted 4:03 PM ET | CRDFCardiff Oncology, Inc. | 5.03Bylaws / fiscal year8.01Other events | DocumentSEC ↗ |
May 2, 2024 accepted 4:10 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Apr 8, 2024 accepted 4:07 PM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Feb 29, 2024 accepted 4:08 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release7.01Reg FD disclosure | DocumentSEC ↗ |
Jan 8, 2024 accepted 9:12 AM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Nov 2, 2023 accepted 4:06 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release7.01Reg FD disclosure | DocumentSEC ↗ |
Sep 26, 2023 accepted 4:07 PM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Aug 9, 2023 accepted 4:06 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release5.03Bylaws / fiscal year | DocumentSEC ↗ |
Aug 7, 2023 accepted 4:42 PM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Jul 24, 2023 accepted 5:13 PM ET | CRDFCardiff Oncology, Inc. | 8.01Other events | DocumentSEC ↗ |
Jun 20, 2023 accepted 5:24 PM ET | CRDFCardiff Oncology, Inc. | 8.01Other events | DocumentSEC ↗ |
Jun 15, 2023 accepted 4:45 PM ET | CRDFCardiff Oncology, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
May 4, 2023 accepted 4:01 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Mar 10, 2023 accepted 4:51 PM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Mar 2, 2023 accepted 4:14 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Feb 2, 2023 accepted 4:02 PM ET | CRDFCardiff Oncology, Inc. | 5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Nov 3, 2022 accepted 4:14 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Oct 3, 2022 accepted 4:12 PM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Sep 12, 2022 accepted 4:09 PM ET | CRDFCardiff Oncology, Inc. | 7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Sep 6, 2022 accepted 4:07 PM ET | CRDFCardiff Oncology, Inc. | 8.01Other events | DocumentSEC ↗ |
Aug 4, 2022 accepted 4:08 PM ET | CRDFCardiff Oncology, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jun 14, 2022 accepted 4:08 PM ET | CRDFCardiff Oncology, Inc. | 8-K/A 5.07Shareholder vote | DocumentSEC ↗ |
Jun 9, 2022 accepted 5:02 PM ET | CRDFCardiff Oncology, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |